製品詳細
Source
Monoclonal Anti-HRSV F Antibody, Human IgG1 (Palivizumab) is a recombinant chimeric monoclonal antibody expressed in HEK293, which combines the variable region of a mouse monoclonal antibody with human constant domain.
Antibody Type
Recombinant Monoclonal
Isotype
Human IgG1, Kappa
Specificity
This product is a specific antibody specifically reacts with HRSV F-Palivizumab.
Application
ApplicationRecommended UsageELISA0.2-2 μg/mLPurification
Protein A purified / Protein G purified.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Lyophilized
Formulation
Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
Reconstitution
Please refer to the Certificate of Analysis (CoA) for specific instructions.
Shipping
Lyophilized product is shipped at ambient temperature.
Storage
For long term storage, the product should be stored in a lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
お客様はこちらも閲覧
データ表示
Bioactivity-ELISA

Immobilized HRSV (A) Post-fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H6) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-HRSV F Antibody, Human IgG1 (Palivizumab) (Cat. No. HRF-M789) with a linear range of 0.3-5 ng/mL (QC tested).
Protocol
Immobilized HRSV (B) Post-fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H9) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-HRSV F Antibody, Human IgG1 (Palivizumab) (Cat. No. HRF-M789) with a linear range of 0.3-5 ng/mL (QC tested).
Protocol
Immobilized HRSV (A) Pre-fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H7) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-HRSV F Antibody, Human IgG1 (Palivizumab) (Cat. No. HRF-M789) with a linear range of 0.3-5 ng/mL (Routinely tested).
Protocol
Immobilized HRSV (B) Pre-fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H8) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-HRSV F Antibody, Human IgG1 (Palivizumab) (Cat. No. HRF-M789) with a linear range of 0.3-5 ng/mL (Routinely tested).
Protocol
ユーザーレビュー コメントを投稿

バックグランド
Antibody Palivizumab, a humanized monoclonal antibody targeting the antigenic site II region of the RSV F protein.
最新の進展
メールアドレス
order.jp@acrobiosystems.comお問い合わせ
グローバル:+1 800-810-0816(Toll Free)



















